NCT06166823Unknown不适用
Electronic Medical Record Alerts to Optimize Medical Therapy in Heart Failure and Reduced Ejection Fraction in a Low-middle Income Country
Instituto Cardiovascular de Buenos Aires0 个研究点目标入组 240 人开始时间: 2024年1月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 240
- 主要终点
- The primary efficacy endpoint will be the GDMT optimize score in HfrEF patients 90 days after randomization.
研究概览
简要总结
OPTIMAL-HF is a pragmatic, cluster randomized, single-blind intervention trial that will be conducted at an outpatient clinic in Argentina. The trial will assess the effectiveness of an individualized-based alert system compared to usual care in improving GDMT optimization at 90 days in patients with HFrEF.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inclusion Criteria:
- •Eligible patients will include those with an EF ≤ 40% on their most recent echocardiogram, age > 18, and an outpatient cardiology encounter during the study period.
- •Age 18 or over
排除标准
- •under optimal medical treatment
- •palliative care, or undergoing hemodialysis will be excluded
- •Cardiologist
- •Inclusion criteria:
- •Cardiologists from an outpatient clinic at a cardiovascular center in Buenos Aires will be selected for potential participation in the study.
- •Exclusion criteria Cardiologists belonging to the heart failure service
结局指标
主要结局
The primary efficacy endpoint will be the GDMT optimize score in HfrEF patients 90 days after randomization.
时间窗: 90 days
次要结局
未报告次要终点
研究者
Lucrecia Maria Burgos
MD
Instituto Cardiovascular de Buenos Aires
相似试验
已完成
不适用
Study of an Electronic Health Record-embedded Severe Sepsis Early Warning AlertSevere SepsisNCT02376842Stanford University1,149
已完成
不适用
Trial of a Best-Practice Alert in the Electronic Medical Record to Reduce Unnecessary Telemetry MonitoringArrhythmiaNCT02529176University of California, San Francisco1,021
尚未招募
不适用
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)ValvulopathyAortic Regurgitation DiseaseHeart FailureMitral RegurgitationBrain Natriuretic PeptideMitraclipTAVI(Transcatheter Aortic Valve Implantation)Tricuspid RegurgitationAortic StenosisNCT06667128IRCCS Ospedale San Raffaele160
招募中
不适用
Targeted EHR-based Communication of Diagnostic Uncertainty in the EDDiagnostic UncertaintyNCT06638021Thomas Jefferson University300
已完成
不适用
Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart FailureHeart FailureNCT06457152NYU Langone Health1,136